Riedel Richard F, Burfeind William R
DUMC 3305, Durham, North Carolina 27710, USA.
Oncologist. 2006 Sep;11(8):887-94. doi: 10.1634/theoncologist.11-8-887.
Thymoma is a rare tumor with a largely indolent growth pattern. It does, however, have malignant potential as a result of its ability to invade locally and metastasize regionally. Often associated with a number of immune- and nonimmune-mediated paraneoplastic syndromes, patient outcomes are directly related to stage of disease and the ability to achieve a complete surgical resection. Surgery is the mainstay of treatment, with adjuvant radiation recommended for invasive thymoma. Sensitive to both chemotherapy and radiation, durable responses are achievable in incompletely resected and inoperable patients. We present two cases of thymoma followed by a general discussion with an emphasis on treatment for both early and advanced-stage disease.
胸腺瘤是一种罕见肿瘤,生长方式大多较为惰性。然而,由于其具有局部侵袭和区域转移的能力,确实具有恶性潜能。胸腺瘤常与多种免疫和非免疫介导的副肿瘤综合征相关,患者的预后直接与疾病分期以及能否实现完整手术切除有关。手术是主要治疗手段,侵袭性胸腺瘤推荐辅助放疗。胸腺瘤对化疗和放疗均敏感,对于未完全切除和无法手术的患者也可实现持久缓解。我们展示两例胸腺瘤病例,随后进行全面讨论,重点是早期和晚期疾病的治疗。